The S&P 500 healthcare index rose 0.53 percent to help keep the S&P 500 near the unchanged mark, buoyed by strong results and forecasts from Bristol-Myers, up 5.4 percent and Celgene, up 6.4 percent. The two drugmakers were the top boosts to the S&P 500. The S&P real estate sector was down 2.5 percent, its worst decline in nearly six weeks, while utilities shed 0.5 percent. "If we can continue to see actual growth in revenue and growth in EPS, we may see this four-quarter drop in earnings growth come to an end. The S&P 500 posted 16 new 52-week highs and 11 new lows; the Nasdaq Composite recorded 65 new highs and 120 new lows.

Source: The Edge Markets October 27, 2016 22:47 UTC